Mersana Therapeutics, Inc.·4

Jan 16, 4:31 PM ET

Kaufman Michael J. 4

4 · Mersana Therapeutics, Inc. · Filed Jan 16, 2020

Insider Transaction Report

Form 4
Period: 2020-01-15
Kaufman Michael J.
Sr VP Chmistry, Man & Control
Transactions
  • Award

    Stock Option (right to buy)

    2020-01-15+120,000120,000 total
    Exercise: $6.16Exp: 2030-01-15Common Stock (120,000 underlying)
  • Award

    Restricted Stock Units

    2020-01-15+26,66726,667 total
    Common Stock (26,667 underlying)
Footnotes (3)
  • [F1]The options vest in equal quarterly installments over the first four years after the vesting commencement date, January 15, 2020.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  • [F3]The restricted stock units vest in equal annual installments over the first four years after the vesting commencement date, January 15, 2020.

Documents

1 file
  • 4
    a4.xmlPrimary

    4